UnitedHealth Group Incorporated $UNH Shares Sold by Allspring Global Investments Holdings LLC

Key Points

• Allspring Global Investments trimmed its UnitedHealth stake by 4.5% in Q4, selling 7,476 shares and leaving 157,618 shares valued at about $53.0 million; institutional investors own roughly 87.9% of the company.
• Wall Street sentiment is mixed but leaning bullish—Raymond James upgraded UNH to Outperform with a $330 target, analysts call the pullback a buying opportunity, and MarketBeat shows a consensus "Moderate Buy" price target around $363; UnitedHealth also recently beat EPS estimates and pays a $2.21 quarterly dividend (~3.2% yield).
• Ninth Circuit litigation poses meaningful downside risk: the court will decide whether UnitedHealth can use a broad preemption defense in a Medicare Advantage fraud case, and an adverse ruling could increase liability and regulatory scrutiny.

Allspring Global Investments Holdings LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 157,618 shares of the healthcare conglomerate's stock after selling 7,476 shares during the period. Allspring Global Investments Holdings LLC's holdings in UnitedHealth Group were worth $53,023,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of UNH. Beacon Financial Strategies CORP purchased a new stake in UnitedHealth Group in the fourth quarter valued at $26,000. Foster Dykema Cabot & Partners LLC boosted its position in shares of UnitedHealth Group by 69.4% in the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 34 shares during the period. 1248 Management LLC acquired a new position in UnitedHealth Group during the third quarter worth approximately $29,000. Holos Integrated Wealth LLC purchased a new stake in UnitedHealth Group in the fourth quarter valued at approximately $29,000. Finally, Hurley Capital LLC grew its position in shares of UnitedHealth Group by 81.6% during the third quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock worth $31,000 after acquiring an additional 40 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH to Outperform and set a $330 price target, citing better-than-expected expense/margin improvement (especially at Optum Health), which implies meaningful upside to earnings estimates. Raymond James upgrade
• Positive Sentiment: Prominent analyst pieces argue UNH is deeply discounted after steep declines and that the pullback creates a buying opportunity for value/long-term investors. That narrative can attract contrarian flows. Investopedia buy argument
• Positive Sentiment: Reports that billionaire Paul Tudor Jones is adding to UNH provide a headline-driven catalyst and signal institutional conviction for some macro-focused allocators. Paul Tudor Jones buys
• Positive Sentiment: Analysis from Zacks highlights UNH’s strong earnings surprise history and argues the company has the setup to beat upcoming quarters—supporting the bullish case tied to margin recovery. Zacks on earnings upside
• Neutral Sentiment: Street coverage remains heavy and mixed: many buy/outperform ratings and a median multi-month price target well above current levels, so analyst sentiment provides a backdrop for both rallies and volatility. QuiverQuant analyst/target summary
• Negative Sentiment: Social-media and trader chatter intensified after shares fell below Berkshire’s purchase price, spotlighting year-to-date and prior-year declines; that panic plus recent large institutional sell-offs increases downside volatility risk. QuiverQuant social discussion
• Negative Sentiment: Legal/regulatory risk remains unresolved: the Ninth Circuit will weigh whether United can use a broad preemption defense in a Medicare Advantage fraud case—an adverse ruling could increase liability exposure and regulatory scrutiny. Ninth Circuit legal risk

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $274.04 on Thursday. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $286.16 and a 200 day moving average price of $320.70. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a market cap of $248.74 billion, a P/E ratio of 20.78, a PEG ratio of 1.24 and a beta of 0.40.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the prior year, the business posted $6.81 EPS. The company's revenue for the quarter was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.2%. UnitedHealth Group's dividend payout ratio is 67.02%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on UNH. KeyCorp reiterated an "overweight" rating on shares of UnitedHealth Group in a research note on Wednesday, January 28th. Raymond James Financial upgraded shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 target price for the company in a research note on Wednesday. Mizuho dropped their price target on UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a research report on Thursday, February 5th. Jefferies Financial Group lowered their target price on UnitedHealth Group from $418.00 to $340.00 and set a "buy" rating on the stock in a research note on Wednesday, January 28th. Finally, Morgan Stanley cut their price target on UnitedHealth Group from $411.00 to $409.00 and set an "overweight" rating for the company in a research note on Friday, January 23rd. One investment analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $363.38.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.